MaxART: Early Access to ART for All in Swaziland

NACompletedINTERVENTIONAL
Enrollment

3,485

Participants

Timeline

Start Date

September 1, 2014

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
HIV/AIDS
Interventions
OTHER

Early Access to ART for All

All HIV-positive individuals will be initiated on Swaziland's recommended first-line ART regimen, unless contraindicated when recommended alternate regimens will be used per national guidelines.

Trial Locations (1)

Unknown

Swaziland Ministry of Health, Mbabane

All Listed Sponsors
collaborator

Ministry of Health, Swaziland

OTHER_GOV

collaborator

STOP AIDS NOW! (SAN!)

UNKNOWN

collaborator

Swaziland National Network of People Living with HIV/AIDS (SWANNEPHA)

UNKNOWN

collaborator

Southern African AIDS Information Dissemination Service (SAfAIDS)

UNKNOWN

collaborator

Southern African Centre for Epidemiological Modelling and Analyses (SACEMA)

UNKNOWN

collaborator

University of Amsterdam

OTHER

collaborator

Harvard School of Public Health (HSPH)

OTHER

lead

Clinton Health Access Initiative Inc.

OTHER

NCT02909218 - MaxART: Early Access to ART for All in Swaziland | Biotech Hunter | Biotech Hunter